CHA ÀÇ°úÇдëÇб³ Â÷º´¿ø professor

±³¼ö´Ô»çÁø
  • ¾ÈÈñÁ¤
  • ¼Ò ¼Ó: ºÐ´çÂ÷º´¿ø
  • Àü¹®ºÐ¾ß : »êºÎÀΰúº´¸®, ³­¼Òº´¸®, À¯¹æº´¸®, ºÐÀÚº´¸®
  • Á÷ À§: ±³¼ö
  • ¸Þ ÀÏ: ºñ°ø°³
  • Àü È­: 1577-4488
  • ÆÑ ½º:
  • ÁÖ ¼Ò: °æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßž·Î 59
  • ȨÆäÀÌÁö:
  • ·Î±×ÀÎ

ÅǸ޴º

ÁÖ¿ä¹ßÇ¥³í¹®

ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£ ±¸ºÐ Á¦¸ñ
225 (±¹¿Ü)SCI Association between microRNA machinery gene polymorphisms and recurrent implantation failure
224 (±¹³»)SCIE Clinical Impact of Somatic Variants in Homologous Recombination Repair-Related Genes in Ovarian High-Grade Serous Carcinoma
223 (±¹¿Ü)SCI Immune gene signatures for predicting durable clinical benefit of anti-PD-1 immunotherapy in patients with non-small cell lung cancer.
222 (±¹¿Ü)SCI ZEB1 collaborates with ELK3 to repress E-cadherin expression in triple-negative breast cancer cells
221 (±¹¿Ü)SCI Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review
220 (±¹¿Ü)SCI Multifunctional nanoparticles for genetic engineering and bioimaging of natural killer (NK) cell therapeutics
219 (±¹¿Ü)SCIE STING signaling is a potential immunotherapeutic target in colorectal cancer
218 (±¹¿Ü)SCI STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade
217 (±¹¿Ü)SCIE Empagliflozin attenuates diabetic tubulopathy by improving mitochondrial fragmentation and autophagy
216 (±¹¿Ü)±âŸ IL-27 Enhances IL-15/IL-18-mediated Activation of Human Natural Killer Cells
ÀÌÀüÆäÀÌÁö À̵¿ 1 2 3 4 5 6 7 8 9 10 ´ÙÀ½ÆäÀÌÁö À̵¿
Copyright ¨Ï chamc, All rights reserved.

ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à

  • °­³²Â÷º´¿ø
  • ºÐ´çÂ÷º´¿ø
  • ºÐ´çÂ÷¿©¼ºº´¿ø
  • ±¸¹ÌÂ÷º´¿ø
  • ¿©¼ºÀÇÇבּ¸¼Ò
  • Â÷¿ò

ÀüÈ­¹®ÀÇ

  • °­³²Â÷º´¿ø 02.3468.3000
  • ºÐ´çÂ÷º´¿ø 031.780.5000
  • Â÷¿ò 02.3015.5300
  • ±¸¹ÌÂ÷º´¿ø 054.450.9700
  • ´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
  • °­³²°ÇÁø¼¾ÅÍ 02.2191.3900
  • ºÐ´çÁ¾ÇÕ°Ç°­ÁõÁø¼¾ÅÍ 031.780.5940
  • ½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
  • ±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
  • ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729